Last reviewed · How we verify
NCT05048381
miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB)
trial testing Next Generation Sequencing in Active Tuberculosis. Withdrawn.
31 October 2022
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 6 September 2021 |
| Primary completion | 31 October 2022 |
| Estimated completion | 31 October 2022 |
Drugs / interventions tested
- Next Generation Sequencing
Conditions studied
- Active Tuberculosis — all drugs for Active Tuberculosis →
Sponsor
University Hospital, Basel, Switzerland
Who can join
18 and older, any sex, with Active Tuberculosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The detection of miRNA (non-coding ribonucleic acid) in the blood in the context of active tuberculosis is an innovative approach to the detection of new disease-specific biomarkers. The primary goal of this analysis is to define, for the first time, an miRNA fingerprint for tuberculosis in sweat. Samples that were collected as part of the Sweatb Study (NCT03667742) project are examined for the occurrence of disease-specific, non-coding miRNAs to define new biomarkers in the sweat. These biomarkers can be detected non-invasively and will help in the detection of patients with active tuberculosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05048381
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Next Generation Sequencing
Trials testing the same drug.
- NCT06996561 — Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management · Phase 2, PHASE3 · recruiting
- NCT05254145 — Joint Microbiome Study for the Knee · unknown
- NCT05046444 — Solving Riddles Through Sequencing · recruiting
- NCT05013203 — NGS for Spine Surgery Patients · unknown
- NCT03578445 — Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions · NA · completed
Other recruiting trials for Active Tuberculosis
Currently open trials in the same condition.
- NCT05045391 — Pulmonary Aspergillosis in Tuberculosis Patients · active not recruiting
- NCT06838780 — Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct · active not recruiting
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05048381 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 1 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05048381.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing